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Abstract 
 
Black pepper (Piper nigrum L.), one of the most popular Indonesian spices has been 
reported to possess various therapeutic effects. The aim of this study is to evaluate the 
cytotoxicity and antigenotoxicity of black pepper ethanolic extract (BPE) and its combination with 
doxorubicin (Dox) on CHO-K1 cells. Based on thin layer chromatography analysis, BPE contained 
piperine. Under MTT assay, BPE showed cytotoxic effect with the IC50 value of 68 μg/mL and 
performed synergism in combination with Dox. In vitro micronucleus test using Giemsa staining 
revealed that BPE did not cause morphological changes qualitatively on CHO-K1 cells at 
concentration of 8.5 μg/mL, whereas using flow cytometry analysis showed that BPE could 
decrease the number of micronucleus (MN) formation induced by doxorubicin. In addition, BPE 
reduced the ROS level on the CHO-K1 cells which observed by reactive oxygen species (ROS) 
intracellular assay. The decrease in ROS level indicated that the antioxidant activity of BPE 
contribute to the antigenotoxicity. Furthermore, molecular docking performed that piperine 
interacted with DNA Topoisomerase II with docking score of -80.68. Overall, BPE performed 
cytotoxic effect in single treatment, increased the cytotoxicity and reduced the genotoxicity of 
doxorubicin. Thus, BPE has potential to be developed further as co-chemotherapeutic and 
antigenotoxic agent. 
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INTRODUCTION 
 
Spices are common food ingredient consumed 
by Asian people to make several foods taste better. 
One of the most famous spices with its distinctive 
spicy flavor and aroma is black pepper (Piper 
nigrum L.) that is widely cultivated in tropical 
countries such as Indonesia (Damanhouri and 
Ahmad, 2014). Alongside being a supplementary 
ingredient in food, the community empirically has 
utilized black pepper as a body warmer, stamina 
enhancer, and one of the components in traditional 
medicine (Ahmad, et al., 2012). Particularly, in the 
field of drug development, the exploration of the 
medical benefits of this spice becomes a challenge. 
Black pepper is known to contain piperine or 
1-peperoyl piperidine (Fig. 1a) as the major 
compound which the first active compound that 
isolated from different members of Piperaceae 
family and was found to possesss diverse 
pharmacological activities (Damanhouri and Ahmad, 
2014). Piperine has been studied to have potentially 
various therapeutic activities such as 
antihypertensive and antiplatelets (Taqvi, et al., 
2008), antiasthmatics (Parganiha, et al., 2011), 
antipyretic, analgesic, anti-in ammatory, anti-
diarrheal, antispasmodic, anxiolytic, antidepressants 
(Li, et al., 2007), hepatoprotective (Bajad et al., 
2001), anti-inflammatory, antioxidant, antitumor 
(Manoharan, et al., 2009), immunomodulator, 
immunostimulant, antibacterial, antifungal, and may 
increase the bioavailability of the drug in the body 
(Meghwal, et al., 2013).  
Although black pepper has been widely used 
routinely as a spice or herbal medicine, there has not 
been much evaluation of the genotoxicity of black 
pepper extract using CHO-K1 cells as a common 
model for gentoxicity test.  
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The genotoxicity of piperine has been 
investigated by several scientists; reverse mutation 
assays in Salmonella typhimurium (Ames Test) 
showed negative result (Andrews, et al., 1980). An 
in vitro micronucleus test using hepatoma cells 
(H4IIEC3/G-cells) was negative response (Singh, et 
al., 1994), while in vivo Comet assay in lungs of 
male mice (Selvendiran, et al., 2005) at 
concentration levels of up to 75 mg/kg bw performed 
no genotoxic activities. Piperine has also no 
genotoxic potential under MNT in vitro and in vivo 
evaluation (Thiel, et al., 2014). Therefore, this study 
convey information regarding to the antigenotoxicity 
of black pepper extract especially in combination 
with doxorubicin (Dox). 
This study aims to evaluate the cytotoxic and 
antigenotoxic effects of black pepper ethanolic 
extract (BPE) through in vitro modeling system 
using the Chinese hamster ovary (CHO-K1) cells 
solely and its combination with Dox. CHO-K1 cells 
was exerted as a model of proliferative cells and Dox 
for modelling a genotoxic inducer. Genotoxic effect 
was analyzed by cytokinesis-block micronucleus 
(CBMN) assay through staining with Giemsa and 
counting the micronucleus formation. Moreover, we 
also measured reactive oxigen species (ROS) level 
using DCFDA reagent. The findings from this 
research can be useful for the development of BPE 
as co-chemotherapeutic agent overcoming the 
cytotoxicity of Dox.  
 
MATERIALS AND METHODS 
 
Extract Preparation and Identification 
Chemical Compound of BPE 
Black pepper (Piper nigrum L.) powder form 
was obtained from Balai Materia Medika Batu, 
Malang, East Java and determined at the same place. 
Black pepper powder was macerated by ethanol p.a. 
(Merck) for 24 hours and concentrated by 
evaporating the solven. The identification of the 
chemical content in BPE was carried out using thin 
layer chromatography (TLC) with silica gel 60 F254 
as the stationary phase and dichlorometan:ethyl 
acetate (3:1 v/v) as the mobile phase. Spots were 
identified under UV 254 nm and UV 366 nm. 
 
 
 
CHO-K1 Cell Culture 
CHO-K1 cells were obtained from Prof. 
Masashi Kawaichi, Nara Institute of Science and 
Technology, Japan. The cells were cultured in 
Rosewell Park Memorial Institute (RPMI) medium 
(Gibco) supplemented with 10 % 
v
/v Fetal Bovine 
Serum (FBS) (Sigma), Fungizone 1.25 µg/mL and 
150 U/mL Penicillin - 150 µg/mL Streptomycin 
(Gibco) at 37
o
C and 5 % CO2. Trypsin-EDTA 
0.25% (Gibco) was used to detach cells from tissue 
culture dish.  
 
Cytotoxicity Assay 
Cytotoxic assay was performed using MTT 
assay. Cells (briefly 8 x 10
3
 cells/well) were 
transferred to 96-wellplate and then incubated for 24 
hours. Cells were treated with BPE, Dox, and their 
combination and then incubated for 24 hours. After 
24 hours, medium was removed and cells were 
washed with 100 mL of PBS. Then 100 mL of MTT 
reagent with final concentration of 0.5 mg/mL in 
medium was added into each well and incubated 
again for 4 hours to form formazan crystal. The 
stopper reagent (10% SDS in 0.01 N HCl) was used 
to dissolve then the cell were incubated overnight at 
room temperature and in the dark (covered with 
alumunium foil). The next day, the absorbance from 
each well was measured by ELISA reader with 595 
nm wavelength then converted to cells viability 
percent. 
 
ROS Intracellular Assay 
CHO-K1 cells (briefly 5x10
4
 cells/well) were 
transferred into 24-wellplate and incubated for 24 
hours. After 24 hours, medium was removed and 
cells were washed with PBS. Cells were detached 
using 200 μL trypsin-EDTA per well. Trypsin was 
inactivated using 450 μL 1X supplemented buffer 
per well. Cells were collected and transferred into 
microtube then stained with DCFDA (2',7'-
dichlorofluorescin diacetate) as much as 25 μM/well 
and incubated for 30 minutes in 37
o
C incubator. 
After 30 minutes, cells were treated with BPE, 
doxorubicin and their combination and incubated for 
4 hours. ROS analysis performed using flow 
cytometry at wavelength of Ex485 nm/Em535 nm. 
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CBMN Assay using Giemsa Staining 
CHO-K1 cells (briefly 1.2x10
4
 cells/well) 
were seeded on coverslips in 24-wellplate and 
incubated for 24 hours. Cells were treated with BPE, 
Dox, and their combination then incubated for 24 
hours. After 24 hours, medium was removed and 
washed with 500 μL of PBS per well. Cells were 
fixed with 500 μL of cold hypotonic solution (KCl 
0.075 M) and incubated for 6 minutes. The cold 
hypotonic solution was discarded then added 500 μL 
of methanol:acetic acid (3:1) solution and incubated 
for 30 minutes. Cells were stained using 500 μL of 
5% Giemsa and incubated for 1 hour. Coverslips 
were removed from wells to object glasses. 
Observation was performed under light microscope 
with 400x magnifications.  
 
CBMN Assay using Flow cytometry 
The genotoxic flow cytometry assay was 
performed as describe previously with slightly 
modification (Avlasevich, et al., 2006). CHO-K1 
cells (briefly 5x10
4
 cells/well) were seeded in 6-
wellplate and incubated for 24 hours. Then, cells 
were treated with various concentrations of BPE, 
Dox, and their combination and incubated for 24 
hours. After 24 hours, cell medium was transferred 
into conical tube. Cells were washed with PBS of 
500 μL and placed in conical tube. As much as 200 
μL of trypsin-EDTA was added and incubated for 3 
minutes. Tripsin was inactivated by added 1 mL of 
medium. Cells suspension were transferred into 
conical tube and centrifuged at 1500 rpm for 5 
minutes. As much as 100 μL of Nucleic Acid Dye 
Working Solution was added then soaked in ice and 
irradiated with a light source for 20 minutes. As 
much as 3 mL of cold buffer solution was added and 
placed in dark room. The cells were centrifuged at 
1500 rpm for 5 minutes. The supernatant was 
removed then the cell pellet was resuspended with 1 
mL of Complete Lysis Solution 1 and incubated at 
room temperature for 1 hour. Lysis Solution 1 was 
prepared with aquabides, 0.584 mg/mL NaCl, 1 
mg/mL sodium citrate, 0.3 μL/mL IGEPAL, 1 
mg/mL Rnase A (Sigma) and 0.4 μL/mL SYTOX 
Green (Life Technologies). Furthermore, 1 mL of 
Complete Lysis Solution 2 was added and incubated 
at room temperature for 30 minutes. Lysis Solution 2 
was prepared with aquabides, 85.6 mg/mL sucrose 
(Merck), 15 mg/mL citric acid (Merck), and 0.4 
μL/mL of SYTOX Green. Then, samples were 
analyzed using flow cytometer. 
 
Molecular Docking  
Molecular docking was performed to evaluate 
the interaction between piperine and DNA 
Topoisomerase II protein (PDB ID: 4GOV). Piperine 
structure was prepared using Marvin Sketch while 
DNA Topoisomerase protein was obtained from 
protein Data Bank (http://www.pdb.org/). Validation 
was done with parameter value of RMSD (Root 
Mean Square Distances) where RMSD value is must 
be less than 2 Ǻ (Purnomo, 2011). Docking was 
done using PLANTS software to obtain docking 
score. Docking score indicates the chemical bonding 
strength between ligand and receptor.  
 
RESULTS 
 
Extraction and Identification of BPE 
Phytochemical Content  
From maceration, we gained viscous black 
pepper extract (BPE) of 6.89% (w/w) yield. 
Qualitative identification of the phytochemical 
content of BPE was performed by using TLC. The 
result showed that there was same spot between the 
piperine and BPE sample at hRf value of 82.5 which 
indicated similar polarity between chemical 
component of BPE and piperine standard (Fig. 1b). 
This phenomenon was predicted that BPE contained 
piperine as its chemical compound. 
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Figure 1.  Chemical structure and phytochemical profile of piperine in BPE. (a) Chemical structure of piperine as 
the major compound of BPE. (b) Chromatogram profile of piperine by thin layer chromatography (TLC). The 
elution was carried out with a silica gel 60 F254 as stationary phase and the dichloromethane:ethyl acetate (3:1 v/v) as 
mobile phase with an elution distance of 8 cm. Detection was performed under UV254 and UV366. (P: piperine 
standard; S:BPE sample). 
 
 
Effects of BPE and Its Combination With 
Dox on CHO-K1 Cells Viabillity and 
Intracellular ROS Level 
Cytotoxic assay was performed using MTT 
Assay to determine the effect of BPE on CHO-K1 
cells viability. The results indicated that BPE caused 
reduction of cells viability with IC50 value of 68 
µg/mL (Fig. 2). IC50 value was used as fundamental 
to determine concentration used in followed 
experiments. 
Dox was used in combination treatment as one 
of chemotherapeutic agents that can cause cell 
toxicity through the mechanism of inhibition of 
DNA Topoisomerase II, intercalation with DNA 
causing inhibition of DNA synthesis, as well as the 
formation of free radicals of semiquinone and 
oxygen free radicals (Bruton, et al., 2005). 
Combination treatment of BPE and Dox was 
revealed by using BPE concentration of 8.5 μg/mL 
while the concentrations of doxorubicin used were 1, 
2, and 4 μM. The combination could decrease cell 
viability greater than single treatment (Fig. 2b). In 
addition, the combination treatment has combination 
index (CI) value of <1 which indicated synergistic 
activity between BPE and Dox (Fig. 2c). These 
results suggested that BPE could be developed as a 
co-chemotherapeutic agent against cancer cells in 
order to improve the effectiveness of Dox. 
ROS (Reactive Oxygen Species) intracellular 
assay was aimed to determine the ability of BPE in 
lowering ROS levels in CHO-K1 cells. The results 
showed decreasing in fluorescence intensity which 
indicated reducing of intracellular ROS in CHO-K1 
cells (Fig. 2d). That phenomenon was probably due 
to the antioxidant activity of BPE. This result 
strengthened the potency of BPE as antigenotoxic 
agent by neutralizing radical compound which cause 
DNA damage. 
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Figure 2. Effect of single treatment of BPE and the combination with Dox on cell viability and intracellular 
ROS levels on CHO-K1 cells. Cytotoxic effect of BPE (a) and the combination with Dox (b and c) were 
conducted by MTT assay, CHO-K1 cells (1x104 cells/well) were treated with the compounds in the concentration as 
indicated for 24-h. The IC50 values were important to the further assays and were calculated by using linear 
regression in three independent experiments. The intracellular ROS level of BPE was measured using flow cytometry 
with DCFDA staining. (d) Histograms of ROS-positive cell percentage by mean of DCF fluorescence intensity. 
 
Effects of BPE on Micronucleus Formation 
Micronucleus is one of parameter to 
determine genetic damage. Micronucleus would be 
expressed on imperfectly divided cells because of 
DNA damage. Damaged DNA is unable to reach the 
spindle string during mitosis. Therefore, in telophase 
stage, cells form nuclear membrane that would cover 
damaged DNA and form small nucleus called 
micronucleus (Fenech, 2000). 
Based on qualitative observation of CBMN 
assay, Dox 1 μM treatment showed micronucleus 
formation and changed in cell morphology while in 
BPE 8.5 μg/mL treatment, it was not found 
morphological changes. However, in the 
combination of BPE and Dox, the micronucleus 
formation was difficult to observe (Fig. 3a). These 
results qualitatively showed that low concentrations 
of BPE did not induce genotoxic in CHO-K1 cells. 
Genotoxic assay using flowcytometry 
revealed that Dox 1 μM did not induce micronucleus 
formation. However, doxorubicin 2 nM showed 
micronucleus formation with MN percentage of 
94.83% while BPE 17 and 34 μg/mL did not show 
micronucleus formation. In combination of Dox and 
BPE found that BPE could decrease the 
micronucleus percentage (Fig. 3b). This results 
suggested that BPE is potential as an antigenotoxic 
agent on CHO-K1 cells. 
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Figure 3.  Effects of BPE administration on micronucleus formation in CHO-K1 cells. CHO-K1 cells of 12 x 103 
cells/plants were seeded on coverslip within 24-wellplate for CBMN test and 5 x 104 cells/wells in 6-wellplate for 
genotoxic test with flowcytometry. Cells were treated with BPE, Dox, and their combination.  (a) Cell morphology 
of CHO-K1 after being stained with Giemsa 5%. The observation was done using light microscope with 400x 
magnification. (b) Percentage of  micronucleus formation on CHO-K1 cells. 
 
 
Molecular Interaction between Piperine and 
DNA Topoisomerase II 
Molecular docking was done to predict 
interaction of active compound in BPE toward DNA 
Topoisomerase II protein as the molecular target of 
Dox. Native ligand mitoxantron was used to 
compare the interaction of piperine on DNA 
Topoisomerase II protein. The lower docking score 
then easier to form bonding between ligand and 
protein target. Docking score of ligand and DNA 
Topoisomerase II was showed in Fig. 4a. The 
docking results showed piperine had lower affinity 
than mitoxantron on DNA Topoisomerase II protein 
because it had higher docking score than 
mitoxantron. Therefore, piperine could compete 
with mitoxantron in binding with DNA 
Topoisomerase II protein and might decrease the 
possibility of DNA damage. 
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Figure 4. Interaction between mitoxantron (native ligand), Dox, and piperine on DNA Topoisomerase II. 
Mitoxantron (native ligand), Dox, and piperine structures were prepared using MarvinSketch while DNA 
Topoisomerase II was prepared using YASARA. Docking simulation was performend using PLANTS software. (a) 
Docking score and (b) 3D visualization of interaction.  
 
 
DISCUSSION 
 
Genetic instability as an indicator of exposure 
to genotoxic agents is the common phenomena 
leading to the disease, included cancer. Dox is well 
known as the most common chemotherapeutic agent 
compared to another agent due to the strong 
cytotoxic activity (Cardoso, et al., 2009). However, 
Dox reported to possess genotoxicity that is caused 
by the produce of oxidative stress which reduces the 
activity of antioxidant, increase the lipid peroxidase 
and increase intracellular ROS level such as 
superoxide radical anion, hydroxyl radical, and 
singlet oxygen. This mechanism leads to the cell 
death and the micronucleus formation (Bryce, et al., 
2010). Hence, an agent that possess strong cytotoxic 
activity as well as reduce the genotoxicity of 
doxorubicin are considered to develop a new co-
chemotherapeutic agent. 
The results of our study showed that the 
single treatment of BPE reduced the viability of 
CHO-K1 cells in dose dependent manner and gave 
IC50 value of 68 µg/mL. Based on Prayong, et al. 
(2008), the IC50 value of BPE on CHO-K1 cells was 
below 100 μg/mL meaning that BPE has strong 
cytotoxic activity. The result was in accordance with 
the previous studies, in which BPE was found to 
have cytotoxic activity on HeLa cell (61.94±0.054 
μg/mL) (Paarakh, et al., 2015), 4T1 cells, and K562 
cells (Lu, et al., 2012). The combination of BPE and 
Dox could also reduce cell viability with 
combination index (CI) value of <1 which indicated 
synergistic activity between BPE and Dox (Fig. 2c). 
This data supported that BPE was potential to be 
developed as co-chemotheraetic agent in order to 
improve the effectiveness of Dox. Thus, we 
continued this research to investigate the 
genotoxicity of BPE in combination with Dox. 
In the genotoxicity study, BPE showed 
antigenotoxic effect and provided protection against 
toxic and genotoxic effects induced by 
chemotherapeutic agent, Dox in in vitro system 
using CHO-K1 cell lines. There were no increases in 
the micronucleus-frequencies of the BPE treated 
group at doses of 17 and 34 μg/mL. The reduction of 
micronucleus also seen in the combination with Dox 
compared to the positive control Dox itself (Fig. 3c). 
The results in the absence of micronucleus formation 
are in line with the previous literature data of 
piperine genotoxicity (Thiel, et al., 2014). To 
conclude on the cytotoxicity and genotoxicity 
potential of piperine, we considered all relevant data 
in several literatures: Piperine was tested under the 
Ames Test (Karekar, et al., 1996) and in vitro MNTs 
(a) 
DNA Topoisomerase II - 
mitoxantron 
DNA Topoisomerase II - 
doxorubicin 
DNA Topoisomerase II - 
piperine 
(b) 
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(Singh, et al., 1994), and showed negative results. 
Moreover, several studies at doses up to 75 mg/kg 
bw in different species showed the absence of 
micronucleus, DNA-strandbreaks, or dominant lethal 
mutation (Karekar, et al., 1996; Muralidhara and 
Narasimhamurthy, 1990; Selvendiran, et al., 2005; 
Balakrishnan, et al., 2008). In addition, several 
research strongly presented evidence for a 
chemopreventive activity of piperine rather than for 
a genotoxic activity (Vellaichamy, et al., 2009; 
Sehgal, et al., 2013). Furthermore, our result 
indicated that BPE performed antioxidant activity 
based on the reducing of intracellular ROS level on 
CHO-K1 cells compared to H2O2 treatment (Fig. 
2d). This result enhanced the potency of BPE as 
antigenotoxic agent might be caused by neutralizing 
free radical compound which cause DNA damage.  
These data suggested that BPE was not 
genotoxic, regardless of the concentration treatment. 
From the combination with Dox, BPE increased 
doxorubicin effectiveness and decreased the 
frequency of micronucleus, indicated that BPE 
reduced any toxic effects of Dox. Different 
mechanism of Dox and piperine might be 
contributed to the combinational cytotoxic effect of 
both. Dox interacts with DNA by intercalation and 
inhibits DNA Topoisomerase II. Therefore, we 
studied about the interaction between piperine and 
DNA Topoisomerase II using molecular docking. 
Molecular docking analysis demonstrated that 
piperine potentially inhibits the target protein, DNA 
Topoisomerase II. Although the docking score of 
piperine was lower than the native ligand, piperine 
could compete with Dox to interact with DNA 
Topoisomerase resulting in the increasing of 
doxorubicin effectiveness therapy. To confirm the 
anti-genotoxic effect of BPE should be conducted by 
mammalian in vivo micronucleus test and the others 
in vitro genotoxicity evaluation such as comet assay 
and DNA fragmentation assay to detect DNA 
damage. In addition, studies should be conducted to 
determine the limit dose in human consumption and 
provide rational concentration for implementing co-
chemotherapeutic and antigenotoxic agent. 
 
CONCLUSION 
 
We summarized that BPE was not induce 
micronucleus formation and could reduce the 
frequency of micronucleus induced by doxorubicin. 
These results suggested that BPE has potency to be 
developed as an agent for preventing genetic 
damage. In addition, cytotoxic combination assay 
indicated that BPE might increase cytotoxic effect of 
doxorubicin on CHO-K1 cells. Therefore, BPE 
could be developed as co-chemotherapeutic agent to 
improve the effectiveness of doxorubicin therapy. 
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